IP Library Granted Patent US 7,381,525
Granted Patent B1
US 7,381,525 · App. 08/873,597 · Granted Jun 3, 2008

AC/DC voltage apparatus for detection of nucleic acids

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,381,525
App. No.
08/873,597
Granted
Jun 3, 2008
Kind
B1
Abstract

The invention relates to nucleic acids covalently coupled to electrodes via conductive oligomers. More particularly, the invention is directed to the site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials, and to methods of making and using them.

Claims (35)

1. An apparatus for the detection of target nucleic acids in a test sample, comprising:

a) a test chamber comprising a first and a second electrode, wherein said first electrode comprises:

i. a single stranded nucleic acid covalently attached to said electrode via an insulator, wherein said insulator is an alkyl oligomer wherein each monomer of said alkyl oligomer is independently selected from the group consisting of: —(CH 2 ) n —, —(CRH) n —, —(CR2) n —, ethylene glycol and ethylene glycol derivatives using other heteroatoms in place of oxygen; wherein n is from 1 to 16; and wherein R is selected from the group consisting of hydrogen, alkyl, alcohol, aromatic amino, amido, nitro, ethers, esters, aldehydes, sulfonyl, silicon moieties, halogens, sulfur containing moieties, phosphorous containing moieties, and

ii. a passivation agent monolayer; and

b) an AC/DC voltage source electrically connected to said first and second electrodes.

2. An apparatus accordingly to claim 1 further comprising,

c) a second nucleic acid covalently attached to an electron transfer moiety.

3. An apparatus for the detection of target nucleic acids in a test sample, comprising:

a) a test chamber comprising a first and a second electrode, wherein said first electrode comprises:

i. a covalently attached single stranded nucleic acid attached to said first electrode via an insulator, wherein said insulator is an alkyl oligomer wherein each monomer of said alkyl oligomer is independently selected from the group consisting of: —(CH 2 ) n —, —(CRH) n —, ethylene glycol and ethylene glycol derivatives using other heteroatoms in place of oxygen; wherein n is from 1 to 16; and wherein R is selected from the group consisting of hydrogen, alkyl alcohol, aromatic amino, amido, nitro, ethers, esters, aldehydes, sulfonyl, silicon moieties, halogens, sulfur containing moieties, phosphorous containing moieties;

ii. a passivation agent monolayer; and

iii. a covalently attached first electron transfer moiety; and

b) an AC/DC voltage source electrically connected to said test chamber.

4. An apparatus for the detection of target nucleic acids in a test sample, comprising:

a. a test chamber comprising a first and a second electrode, wherein said first electrode comprises:

i. a covalently attached first single stranded nucleic acid attached to said first electrode via an insulator, wherein said insulator is an alkyl oligomer wherein each monomer of said alkyl oligomer is independently selected from the group consisting of: —(CH 2 ) n —, —(CRH) n —, —(CR2) n —, ethylene glycol and ethylene glycol derivatives using other heteroatoms in place of oxygen; wherein n is from 1 to 16; and wherein R is selected from the group consisting of hydrogen, alkyl, alcohol, aromatic amino, amido, nitro, ethers, esters, aldehydes, sulfonyl, silicon moieties, halogens, sulfur containing moieties, phosphorous containing moieties; and

ii. a passivation agent monolayer; and

b) a second nucleic acid covalently attached to an electron transfer moiety; and

c) an AC/DC voltage source electrically connected to said test chamber.

5. An apparatus according to claim 1 , 3 or 4 , further comprising:

a processor coupled to said electrodes.

6. An apparatus according to claim 1 , 3 or 4 , wherein said AC/DC voltage source is capable of delivering frequencies from between about 1 Hz to about 100 kHz.

7. An apparatus according to claim 1 , 3 or 4 wherein said passivation agent monolayer comprises conductive oligomers.

8. An apparatus according to claim 1 , 3 or 4 wherein said passivation agent monolayer comprises insulators.

9. An apparatus according to claims 1 , 3 or 4 wherein said passivation agent monolayer comprises alkyl chains.

10. An apparatus according claim 9 wherein said alkyl chains have the formula C n H x , where n is 1 to 30, and x is 2(n).

11. An apparatus according to claims 1 , 3 or 4 wherein said passivation agent monolayer comprises terminal groups chosen from the group consisting of —(CH 2 ) n —, —(CRH) n —, —(CR2) n —, ethylene glycol and ethylene glycol derivatives using other heteroatoms in place of oxygen; wherein n is from 1 to 16, and wherein R is selected from the group consisting of hydrogen, alkyl, alcohol, aromatic amino, amido, nitro, ethers, esters, aldehydes, sulfonyl, silicon moieties, halogens, sulfur containing moieties, phosphorous containing moieties, and ethylene glycol moieties.

12. An apparatus according to claims 1 , 3 or 4 wherein said passivation agent monolayer comprises both conductive oligomers and insulators.

13. An apparatus for the detection of target nucleic acids in a test sample, comprising:

a) a test chamber comprising an array of electrodes, each electrode comprising

i. a covalently attached single stranded nucleic acid, attached to said electrodes via an insulator, wherein said insulator is an alkyl oligomer wherein each monomer of said alkyl oligomer is independently selected from the group consisting of: —(CH 2 ) n —, —(CRH) n —, —(CR2) n —, ethylene glycol and ethylene glycol derivatives using other heteroatoms in place of oxygen; wherein n is from 1 to 16; and wherein R is selected from the group consisting of hydrogen, alkyl, alcohol, aromatic amino, amido, nitro, ethers, esters, aldehydes, sulfonyl, silicon moieties, halogens, sulfur containing moieties, phosphorous containing moieties; and

ii. a passivation agent monolayer; and

b) an AC/DC voltage source electrically connected to said test chamber.

14. An apparatus according to claim 13 wherein said passivation agent monolayer comprises conductive oligomers.

15. An apparatus according to claim 13 wherein said passivation agent monolayer comprises insulators.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 1998
From: KAYYEM, JON FAIZ; O'CONNOR, STEPHEN D.
To: CLINICAL MICRO SENSORS, INC.
Reel/Frame 008875/0764 →
Continuity (1)
Provisional Application 6004015500 · Mar 7, 1997